Testing effectiveness (Phase 2)Not Yet RecruitingNCT06062485
What this trial is testing
Surufatinib Combined With Toripalimab and AG Regiments for First-line Treatment of Unresectable or Relapsing Metastatic Ampullary Carcinoma
Who this might be right for
Ampullary Carcinoma
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 30